Infectious Gastroenteritis and Risk of Developing Inflammatory Bowel Disease
Overview
Affiliations
Background & Aims: Infectious gastroenteritis (IGE) is known to exacerbate previously diagnosed inflammatory bowel disease (IBD). However, limited data are available describing a causal link between IGE and incident IBD.
Methods: By using a medical encounter data repository of active duty military personnel, a study was conducted to assess IBD risk in subjects with an antecedent case of IGE.
Results: Between 1999 and 2006, there were 3019 incident IBD cases and 11,646 matched controls who were evaluated in a conditional logistic regression model. To control for potential misclassification, IGE episodes within 6 months of IBD diagnosis were excluded as exposures. After adjusting for potential confounders, an episode of IGE increased the risk of IBD (odds ratio, 1.40; 95% confidence interval, 1.19-1.66). The risk was slightly higher for Crohn's disease compared with ulcerative colitis. In addition, there was an approximate 5-fold increase in IBD risk for persons with a previous irritable bowel syndrome diagnosis.
Conclusions: These data support theories that the initiation of IBD is a multifactorial process that might include the disruption of normal gut homeostatic mechanisms. Further studies are warranted to evaluate the pathogen-specific risks, identify susceptible populations, and better understand the pathophysiologic relationship between IGE and IBD.
The Pathogenesis of Inflammatory Bowel Diseases.
Chauhan G, Rieder F Surg Clin North Am. 2025; 105(2):201-215.
PMID: 40015812 PMC: 11868724. DOI: 10.1016/j.suc.2024.10.008.
Do Antibiotics Cause Inflammatory Bowel Disease? A Systematic Review and Meta-Analysis.
Scharf E, Schlattmann P, Stallhofer J, Stallmach A Visc Med. 2025; 41(1):32-47.
PMID: 39927188 PMC: 11801854. DOI: 10.1159/000541601.
Lee T, Liao H, Salim A, Nettleford S, Kleinman K, Carlson B Free Radic Biol Med. 2024; 227:499-507.
PMID: 39662689 PMC: 11757042. DOI: 10.1016/j.freeradbiomed.2024.12.025.
Marild K, Lerchova T, Ostensson M, Imberg H, Stordal K, Ludvigsson J Aliment Pharmacol Ther. 2024; 61(2):323-334.
PMID: 39450871 PMC: 11671729. DOI: 10.1111/apt.18358.
Impact of COVID-19 on Pediatric Inflammatory Bowel Diseases-From Expectations to Reality.
Trandafir L, Spoiala E, Ghiga G, Gimiga N, Budescu P, Lupu V J Pers Med. 2024; 14(4).
PMID: 38673026 PMC: 11051136. DOI: 10.3390/jpm14040399.